Award
National Heart, Lung, and Blood Institute 5R01HL151505-05
Oxylipin Signaling in Congenital Heart Disease
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$433,656.00
Ceiling
$433,656.00
Awarded
December 01, 2024
Identifier
5R01HL151505-05
Award for research on oxylipin signaling in congenital heart disease to explore molecular mechanisms and therapeutic options using human and mouse models.
Description
This project investigates the role of uncharacterized bioactive lipids, oxylipins, in human and mouse cardiac development and their connection with congenital heart disease (CHD). The project aims to provide new preventive and therapeutic options, exploring molecular mechanisms, extracellular matrix organization, and in vivo contributions in mouse models.